Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs

Kanglaite (KLT) is a Chinese medicine antitumor drug independently developed in China, which has been widely used in the treatment of advanced non-small cell lung cancer (NSCLC). The purpose of this study was to systematically evaluate the efficacy and safety of KLT plus epidermal growth factor rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dailong, Li, Wanqiang, Xu, Lu, Che, Yuan, Cheng, Chunlai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771257/
https://www.ncbi.nlm.nih.gov/pubmed/36550917
http://dx.doi.org/10.1097/MD.0000000000032169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771257/
https://www.ncbi.nlm.nih.gov/pubmed/36550917
http://dx.doi.org/10.1097/MD.0000000000032169

Ejemplares similares